Status:

COMPLETED

Assesment of Muscular Unloading in Chronic Obstructive Pulmonary Disease (COPD) Patients With NIV

Lead Sponsor:

Corporacion Parc Tauli

Conditions:

COPD

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Evaluation of high intensity NIMV in terms of physiological parameters has been performed in short-term studies in COPD patients. However, the support pressure levels used in exacerbated patients seem...

Eligibility Criteria

Inclusion

  • Patients with COPD diagnoses based on a spirometry performed the previous year during stability.
  • COPD patients with home NIV treatment of at least 6 months with acceptable compliance and adaptation.
  • Stable patients or just before hospital discharge due to an exacerbation with gasometric stability.

Exclusion

  • Respiratory acidosis in blood gas analysis, just in case of recent exacerbation
  • Patients with restrictive pathology and /or obesity (IMC\>35)
  • Poor quality of EMG signals.

Key Trial Info

Start Date :

November 30 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 3 2021

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03373175

Start Date

November 30 2017

End Date

May 3 2021

Last Update

August 4 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Parc Tauli

Sabadell, Barcelona, Spain, 08208

2

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041